tirzepatide lawsuit in west virginia Lilly asks to join over compounded versions of its weight-loss drugs GLP-1 medications like Ozempic, Wegovy,

The FDA recommends using non-oral contraceptives or adding a barrier method for 4 weeks after initiation and after each dose increase when taking tirzepatide with oral contraceptives

A US District Court upheld the FDAs decision in May 2025

Providers consider appetite patterns, existing medical conditions, lifestyle habits, side effect tolerance, and long-term health goals before recommending treatment

Manufacturing costs, stability challenges, and potential side effects at those raw material quantities make it impractical with current technology

It is crucial to monitor AEs related to the nervous system and metabolism and gastrointestinal tract particularly within the first week after administration, and later within a month for reproductive and endocrine system disorders

Salcedos blog